Reuters Health Features Dr. Sabrina Islam’s Perspective on Antidiabetic Drug Rosiglitazone and Its Association with Cardiovascular Risks

Sabrina Islam, MD, MPH, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University, offered insight to Reuters Health about a study published in the journal BMJ examining patient-level data of antidiabetic medication rosiglitazone and its association with increased cardiovascular risks. Dr. Islam was not involved in the study. MD Alert picked up the Reuters Health article.